These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 27286893)

  • 21. Comparison of structural and functional outcome of aflibercept versus ranibizumab in patients with myopic choroidal neovascularization.
    Howaidy A; Eldaly ZH
    Eur J Ophthalmol; 2021 Jan; 31(1):211-217. PubMed ID: 31690105
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravitreal bevacizumab therapy on an as-per-needed basis in subfoveal choroidal neovascularization secondary to pathological myopia: 2-year outcomes of a prospective case series.
    Iacono P; Parodi MB; Papayannis A; Kontadakis S; Sheth S; Bandello F
    Retina; 2011 Oct; 31(9):1841-7. PubMed ID: 21775926
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HOW VITREOMACULAR INTERFACE MODIFIES THE EFFICACY OF ANTI-VEGF THERAPY FOR MYOPIC CHOROIDAL NEOVASCULARIZATION.
    Iacono P; Battaglia Parodi M; Iuliano L; Bandello F
    Retina; 2018 Jan; 38(1):84-90. PubMed ID: 28098725
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FIVE-YEAR OUTCOMES OF INTRAVITREAL INJECTION OF RANIBIZUMAB FOR THE TREATMENT OF MYOPIC CHOROIDAL NEOVASCULARIZATION.
    Wu TT; Kung YH
    Retina; 2017 Nov; 37(11):2056-2061. PubMed ID: 28590318
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myopic choroidal neovascularization treated by intravitreal bevacizumab: comparison of two different initial doses.
    Ruiz-Moreno JM; Montero JA; Amat-Peral P
    Graefes Arch Clin Exp Ophthalmol; 2011 Apr; 249(4):595-9. PubMed ID: 21234588
    [TBL] [Abstract][Full Text] [Related]  

  • 26. One-Year Outcomes of the Treat-and-Extend Approach with Aflibercept in Age-Related Macular Degeneration: Effects on Typical Choroidal Neovascularization and Retinal Angiomatous Proliferation.
    Castro-Navarro V; Cervera-Taulet E; Montero-Hernández J; Navarro-Palop C
    Ophthalmologica; 2016; 236(4):215-222. PubMed ID: 27997921
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of fixed-dosing aflibercept for treating polypoidal choroidal vasculopathy: 1-year results of the VAULT study.
    Lee JE; Shin JP; Kim HW; Chang W; Kim YC; Lee SJ; Chung IY; Lee JE;
    Graefes Arch Clin Exp Ophthalmol; 2017 Mar; 255(3):493-502. PubMed ID: 27628062
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of visual outcome and regression pattern of myopic choroidal neovascularization after intravitreal bevacizumab or after photodynamic therapy.
    Hayashi K; Ohno-Matsui K; Teramukai S; Shimada N; Moriyama M; Hayashi W; Yoshida T; Tokoro T; Mochizuki M
    Am J Ophthalmol; 2009 Sep; 148(3):396-408. PubMed ID: 19427991
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of Efficacy of Intravitreal Ranibizumab and Aflibercept in Eyes with Myopic Choroidal Neovascularization: 24-Month Follow-Up.
    Korol A; Kustryn T; Zadorozhnyy O; Pasyechnikova N; Kozak I
    J Ocul Pharmacol Ther; 2020 Mar; 36(2):122-125. PubMed ID: 31755809
    [No Abstract]   [Full Text] [Related]  

  • 30. Optical coherence tomography angiography in myopic choroidal neovascularization after intravitreal ranibizumab.
    Cennamo G; Amoroso F; Schiemer S; Velotti N; Alfieri M; de Crecchio G
    Eur J Ophthalmol; 2019 Mar; 29(2):239-243. PubMed ID: 29991290
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of myopic macular degeneration severity on treatment outcomes with intravitreal aflibercept in the MYRROR study.
    Cheung CMG; Ohno-Matsui K; Wong TY; Li T; Asmus F; Leal S;
    Acta Ophthalmol; 2019 Aug; 97(5):e729-e735. PubMed ID: 30690902
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Short-term efficacy of intravitreal Aflibercept injections for retinal angiomatous proliferation.
    Chou HD; Wu WC; Wang NK; Chuang LH; Chen KJ; Lai CC
    BMC Ophthalmol; 2017 Jun; 17(1):104. PubMed ID: 28655307
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety and efficacy of intravitreal injection of conbercept for the treatment of patients with choroidal neovascularization secondary to pathological myopia: Results from the SHINY study.
    Gao L; Song Y; Sun X; Zhang J; Liu Y; Chen Y; Wu Z; Jian Y; Liu X; Lv L; Chen S; Wang YS; Chen N; Ke X; Zhang F
    Acta Ophthalmol; 2024 Jun; 102(4):e577-e586. PubMed ID: 38009430
    [TBL] [Abstract][Full Text] [Related]  

  • 34. INTRAVITREAL INJECTION OF AFLIBERCEPT IN PATIENTS WITH POLYPOIDAL CHOROIDAL VASCULOPATHY: A 3-YEAR FOLLOW-UP.
    Maruyama-Inoue M; Sato S; Yamane S; Kadonosono K
    Retina; 2018 Oct; 38(10):2001-2009. PubMed ID: 28816730
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravitreal bevacizumab treatment for choroidal neovascularization in pathologic myopia: 12-month results.
    Gharbiya M; Allievi F; Mazzeo L; Gabrieli CB
    Am J Ophthalmol; 2009 Jan; 147(1):84-93.e1. PubMed ID: 18774547
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optical Coherence Tomography Angiography to Quantify Choroidal Neovascularization in Response to Aflibercept.
    Takeuchi J; Kataoka K; Ito Y; Takayama K; Yasuma T; Kaneko H; Terasaki H
    Ophthalmologica; 2018; 240(2):90-98. PubMed ID: 29739007
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravitreal aflibercept for the treatment of choroidal neovascularization associated with rubella retinopathy.
    Kiziltoprak H; Yetkin E; Tekin K; Koc M; Akalin İ; Teke MY
    Int Ophthalmol; 2019 Feb; 39(2):477-484. PubMed ID: 29411259
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Change in choroidal thickness after intravitreal injection for treatment of neovascular age-related macular degeneration: Ranibizumab versus aflibercept.
    Kaya F
    J Fr Ophtalmol; 2017 Dec; 40(10):832-838. PubMed ID: 29113742
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term follow-up of choroidal neovascularization in pathological myopia treated with intravitreal ranibizumab.
    Ladaique M; Dirani A; Ambresin A
    Klin Monbl Augenheilkd; 2015 Apr; 232(4):542-7. PubMed ID: 25902117
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neovascular age-related macular degeneration treated with ranibizumab or aflibercept in the same large clinical setting: visual outcome and number of injections.
    Rasmussen A; Sander B; Larsen M; Brandi S; Fuchs J; Hansen LH; Lund-Andersen H
    Acta Ophthalmol; 2017 Mar; 95(2):128-132. PubMed ID: 27535819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.